Lumida
/RCUS
⌘K
Arcus Biosciences Inc

Arcus Biosciences Inc

RCUS
$24.59USD-5.97%-1.56 today

MARKET CAP

3.1B

P/E (TTM)

FWD P/E

DAY RANGE

$24 – $27

52W RANGE

$11
$32

AI Summary

Stalk
Sell NowMedium

RCUS is in Stage 3 distribution and has triggered a support failure pattern with price closing sharply below key intra-month support on high volume, signaling committed selling. Short-term momentum is negative with price rejected at the 9/20/50 EMAs and approaching the 200-day SMA, while the long-term uptrend remains intact above the rising 200-day SMA. The medium-term bias is bearish, and negative short-term conditions favor immediate downside participation. A decisive reclaim of the broken support band and EMAs would invalidate the bearish posture.

  • Management forecasts $5–10B peak sales for casdatifan in RCC market
  • $775M cash as of Q2 2026 funds operations into H2 2028 amid R&D spending cuts
  • Q2 2026 net loss of $91M and full-year revenue guidance of $65–75M underscore weak profitability
Full analysis →

Buying

8

institutions

Selling

6

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY16.42 M506.11 M+1.19 M+53.9%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY3.16 M97.49 M+1.74 M+217.8%0.01%
WP

Woodline Partners LP

Q2 2026

SELL3.01 M92.73 M+-4.55 M-43.2%0.29%
FA

Fisher Asset Management, LLC

Q2 2026

SELL2.14 M65.96 M+-51.01 K+39.4%0.02%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW589.55 K18.18 M+589.55 K+0.0%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

BUY418.24 K13.12 M+337.43 K+686.2%0.00%
MG

Man Group Plc

Q2 2026

BUY137.76 K4.25 M+56.90 K+143.2%0.01%
MM

Millennium Management LLC

Q2 2026

BUYNEW133.11 K4.10 M+133.11 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL83.86 K2.59 M+-2.43 K+38.7%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY84.68 K1.83 M+42.34 K+81.7%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW22.84 K704.31 K+22.84 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL12.73 K392.53 K+-197.00+40.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-424.70 K-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-129.27 K-100.0%0.00%